TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM $3.71B
1-Year Return
19.93%
This Quarter Return
-3.2%
1 Year Return
+19.93%
3 Year Return
+90.1%
5 Year Return
+158.53%
10 Year Return
+284.02%
AUM
$3.36B
AUM Growth
-$1.68B
(-33%)
Cap. Flow
-$1.35B
Cap. Flow
% of AUM
-40.17%
Top 10 Holdings %
Top 10 Hldgs %
28.65%
Holding
6,080
New
403
Increased
1,949
Reduced
2,725
Closed
953
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$249M |
| 2 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$21M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$18.3M |
| 4 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
+$15.6M |
| 5 |
Exxon Mobil
XOM
|
+$14.9M |
Top Sells
| 1 |
Apple
AAPL
|
+$120M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$94.5M |
| 3 |
Microsoft
MSFT
|
+$85.3M |
| 4 |
NVIDIA
NVDA
|
+$83M |
| 5 |
Health Care Select Sector SPDR Fund
XLV
|
+$38.8M |
Sector Composition
| 1 | Technology | 19.99% |
| 2 | Financials | 9.87% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Healthcare | 7.96% |
| 5 | Communication Services | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3276
BT Brands
BTBD
$10.3M
| $14.7K | ﹤0.01% |
11,549
+9,808
| +563% | +$12.5K |
|
3277
AnaptysBio
ANAB
$543M
| $14.6K | ﹤0.01% |
787
-1,910
| -71% | -$35.5K |
|
3278
Embecta
EMBC
$882M
| $14.6K | ﹤0.01% |
1,147
-6,137
| -84% | -$78.3K |
|
|
ECG
3279
Everus Construction Group, Inc.
ECG
$4.02B
| $14.6K | ﹤0.01% |
394
-5,854
| -94% | -$217K |
|
3280
MGP Ingredients
MGPI
$592M
| $14.6K | ﹤0.01% |
497
-5,903
| -92% | -$173K |
|
3281
Bowman Consulting
BWMN
$733M
| $14.6K | ﹤0.01% |
668
+386
| +137% | +$8.43K |
|
3282
NewAmsterdam Pharma
NAMS
$2.76B
| $14.6K | ﹤0.01% |
712
-585
| -45% | -$12K |
|
|
FFNW
3283
DELISTED
First Financial Northwest, Inc
FFNW
| $14.6K | ﹤0.01% |
643
+159
| +33% | +$3.6K |
|
3284
Ooma
OOMA
$350M
| $14.6K | ﹤0.01% |
1,113
+452
| +68% | +$5.92K |
|
3285
American Coastal Insurance
ACIC
$543M
| $14.6K | ﹤0.01% |
1,258
+261
| +26% | +$3.02K |
|
3286
Trevi Therapeutics
TRVI
$972M
| $14.6K | ﹤0.01% |
2,314
-338
| -13% | -$2.13K |
|
3287
TETRA Technologies
TTI
$677M
| $14.6K | ﹤0.01% |
4,332
-17
| -0.4% | -$57 |
|
3288
Vestis
VSTS
$535M
| $14.6K | ﹤0.01% |
1,470
+1,395
| +1,860% | +$13.8K |
|
3289
Heron Therapeutics
HRTX
$227M
| $14.5K | ﹤0.01% |
6,627
-2,258
| -25% | -$4.94K |
|
3290
Foster
FSTR
$292M
| $14.5K | ﹤0.01% |
736
+268
| +57% | +$5.27K |
|
3291
Semler Scientific
SMLR
$410M
| $14.5K | ﹤0.01% |
400
-366
| -48% | -$13.2K |
|
|
BELFB
3292
Bel Fuse Class B
BELFB
$1.88B
| $14.4K | ﹤0.01% |
193
-243
| -56% | -$18.2K |
|
3293
Silicom
SILC
$105M
| $14.4K | ﹤0.01% |
+971
| New | +$14.4K |
|
|
SSBK
3294
DELISTED
Southern States Bancshares
SSBK
| $14.4K | ﹤0.01% |
404
-1,051
| -72% | -$37.6K |
|
3295
Vista Energy
VIST
$3.82B
| $14.4K | ﹤0.01% |
310
-351
| -53% | -$16.3K |
|
3296
Scilex Holding
SCLX
$174M
| $14.4K | ﹤0.01% |
1,657
+620
| +60% | +$5.39K |
|
3297
Sera Prognostics
SERA
$122M
| $14.4K | ﹤0.01% |
3,909
+2,683
| +219% | +$9.87K |
|
|
TSVT
3298
DELISTED
2seventy bio
TSVT
| $14.4K | ﹤0.01% |
2,912
-1,516
| -34% | -$7.49K |
|
|
ARDT
3299
Ardent Health, Inc.
ARDT
$1.83B
| $14.4K | ﹤0.01% |
1,045
+593
| +131% | +$8.15K |
|
3300
UroGen Pharma
URGN
$837M
| $14.4K | ﹤0.01% |
1,320
-265
| -17% | -$2.88K |
|